ACARIZAX 12 SQ-HDM sublingual tablets

ACARIZAX is a sublingual immunotherapy tablet developed by ALK-Abelló, a global leader in allergy treatment. The product is specifically designed to treat house dust mite-induced allergic rhinitis and allergic asthma.

The brand originated in Denmark, where ALK-Abelló has its headquarters and primary production facilities. ALK-Abelló A/S operates as the ultimate owner, specializing in the development of allergy-specific immunotherapy products. Most pharmaceutical production for this specific line is conducted at their facilities in Hørsholm, Denmark, though distribution is managed globally through various international subsidiaries.